Skip to main content
Premium Trial:

Request an Annual Quote

Bionano Genomics' Chinese OEM Partner Nabs NMPA Approval for Sample Prep Products

NEW YORK – Bionano Genomics said on Monday that its Chinese original equipment manufacturing (OEM) partner, A-smart MedTech, has secured reagent class I registrations from China's National Medical Products Administration (NMPA) for the company's DNA extraction and labeling products.

With the NMPA approval, Bionano said the G2 direct label and stain (DLS) DNA labeling kit and the G2 SP bone marrow aspirate (BMA) DNA isolation kit can now be sold for in vitro diagnostic use for reproductive health in independent clinical laboratories and hospitals in China.

A-smart, an assisted reproductive technology company, is Bionano's second OEM partner in China, where the San Diego-based optical genome mapping (OGM) firm is heavily eyeing the clinical market. Bionano previously formed an OEM partnership with Beijing Genome Precision Technology (BGPT), which has obtained NMPA reagent class I registrations for Bionano's DNA extraction kit and labeling products.

"We believe the expansion of NMPA approvals can help make OGM available to China's large population seeking support for reproductive health, including genetic analysis of people considering pregnancy, pre-implantation analysis of in vitro fertilized embryos, and other prenatal and postnatal genome analyses, which we believe will help Bionano grow sales of the company's OGM systems in China," Bionano President and CEO Erik Holmlin said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.